tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

These 3 Stocks Have Strong Upside Potential, Say Five-Star Analysts – 11/27/2025

Story Highlights

If you’re looking for investment ideas right now, several top-rated Wall Street analysts believe that the following stocks are Buys with room to grow from current levels.

These 3 Stocks Have Strong Upside Potential, Say Five-Star Analysts – 11/27/2025

If you’re looking for investment ideas right now, several top-rated Wall Street analysts (each with five-star ratings) believe that the following stocks are Buys with room to grow from current levels. These picks are considered to have solid upside potential based on their research. You can click on any ticker below to explore the company in depth and decide whether it deserves a spot in your portfolio.

TipRanks Black Friday Sale

  1. CG Oncology (CGON) Stock – CG Oncology is a clinical biopharmaceutical company that’s focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. Analyst Sam Slutsky from LifeSci Capital reiterated his Buy rating on the stock and maintained a price target of $90 per share. This equates to an upside of more than 100% from current levels.
  2. Bitdeer Technologies (BTDR) Stock – Bitdeer Technologies Group operates as a technology company for the cryptocurrency mining community. Analyst Gregory Lewis from BTIG reiterated his Buy rating on the stock and maintained a price target of $25 per share. This equates to an upside of more than 97% from current levels.
  3. Coinbase Global (COIN) Stock – Coinbase Global is a leading cryptocurrency technology company headquartered in the United States that operates a digital currency exchange platform. Analyst Gautam Chhugani from Bernstein reiterated his Buy rating on the stock and maintained a price target of $510 per share. This equates to an upside of more than 92% from current levels.

To see the full list of recently rated stocks, visit TipRanks’ Daily Stock Ratings & Price Targets tool.

Disclaimer & DisclosureReport an Issue

1